Table 10.
Outpatient childhood pneumonia antibiotic treatment guidelines
| Age | Preferred/First-Line | Alternative/Second-Line |
|---|---|---|
| 0–5 y | ||
| Viral | No treatment | Antiviral against influenza |
| Bacterial | Amoxicillin | Amoxicillin-clavulanate/third-generation cephalosporin |
| Atypical bacterial | Macrolide | Consult infectious disease |
| Allergy to any of the above | Third-generation cephalosporin/clindamycin | Quinolone |
| 5–16 y | ||
| Viral | No treatment | Antiviral against influenza |
| Bacterial | Amoxicillin | Amoxicillin-clavulanate/third-generation cephalosporin |
| Atypical bacterial | Macrolide or doxycycline | Quinolone if older than 8 years and suspect MDR organism |
| Allergy to any of the above | Third-generation cephalosporin/clindamycin | Quinolone |
Adapted from Cincinnati Children’s Hospital Medical Center. Evidence-based care guideline. Community acquired pneumonia in children 60 days through 17 years of age. Available at: https://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/2011%20CAP%20in%20Children.pdf Accessed February 20, 2018; with permission.